Picture of Johnson & Johnson logo

JNJ — Johnson & Johnson Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+8.61%
3m+17.5%
6m+28.19%
1yr+9.04%
Volume Change (%)
10d/3m-12.27%
Price vs... (%)
52w High-6.83%
50d MA-2.39%
200d MA+2.41%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)16.56
PEG Ratio (f)2.64
EPS Growth (f)6.7%
Dividend Yield (f)2.6%
Valuation (ttm)IndustryMarket
Price to Book Value6.13
Price to Tang. Bookn/a
Price to Free Cashflow23.19
Price to Sales4.82
EV to EBITDA18.32

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.63%
Return on Equity24.96%
Operating Margin19.38%

Financial Summary

Year End 2nd JanUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue$m81,58182,05982,58482,58493,77596,183.89100,221.154.17%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+11.11+13.7-9.04+2.15+31.26+6.85+6.45n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for JNJ

Four signs of a competitive moat at Johnson & Johnson (NYQ:JNJ) background image

Four signs of a competitive moat at Johnson & Johnson (NYQ:JNJ)

Given that widespread uncertainty in the stock market is likely to endure for the rest of 2020 and beyond, it pays to know that you're investing in high-quality stocks, rather than speculative ones. This means safe, profitable companie...

Stock market volatility: Here's a large-cap worth a closer look background image

Stock market volatility: Here's a large-cap worth a closer look

Shares in Johnson & Johnson (NYQ:JNJ) are currently trading at 148.75 but the question for investors is how much the market chaos of 2020 will impact on its price. The answer comes down to judging whether Johnson & Johnson is w...

Johnson & Johnson's strengths in a time of uncertainty background image

Johnson & Johnson's strengths in a time of uncertainty

The best calibre of companies resist competitive threats year-in, year-out, while their competitors fail. This cycle of consistent outperformance and reinvestment can lead to incredible compounding returns – especially in times of worl...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
2nd Jan 20232nd Jan 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Johnson & Johnson EPS forecast chart

Profile Summary

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Directors

Last Annual
January 2nd, 2022
Last Interim
April 3rd, 2022
Incorporated
November 10th, 1887
Public Since
September 25th, 1944
No. of Shareholders
127,899
No. of Employees
141,700
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
2,631,401,804

JNJ Share Price Performance

Latest News for JNJ

Upcoming Events for JNJ

Dividend For JNJB34.SA - 0.3515 BRL

Dividend For JNJ.BA - 0.2260 USD

Dividend For JNJ.N - 1.1300 USD

Johnson & Johnson at UBS Global Healthcare Conference

Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference

Johnson & Johnson at Goldman Sachs Global Healthcare Conference

Q2 2022 Johnson & Johnson Earnings Release

Q2 2022 Johnson & Johnson Earnings Call

Q3 2022 Johnson & Johnson Earnings Call

Q3 2022 Johnson & Johnson Earnings Release

Similar to JNJ

Picture of Abbvie logo

Abbvie

us flag iconNew York Stock Exchange

Picture of Amneal Pharmaceuticals logo

Amneal Pharmaceuticals

us flag iconNew York Stock Exchange

Picture of Bausch Health Companies logo

Bausch Health Companies

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email